Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Valo Health is eligible for a further $1.9 billion in potential milestone payments for up to nine new drug programs "Novo Nordisk, Valo Health Expand Drug Discovery and Development Pact -- Update," at ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

The Dow, S&P 500, and Nasdaq are struggling to find a direction Wednesday as the stock market braces for minutes from the Fed's monetary policy meeting.

Overview: Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥4.37 billion. Operations: ...

The largest project underway is Novo Nordisk’s $4.1 billion expansion ... Fujifilm works with pharmaceutical and biotechnology companies to produce biologics, vaccines and other advanced therapies.

As the demand for these drugs soars, pharmaceutical giants like Novo Nordisk and Eli Lilly have seen massive profits, with Novo’s GLP-1 sales raking in over $6 billion in 2023 alone. Despite the ...

Illustration: Elizabeth Smelov Novo Nordisk’s big bet to improve on the success of its weight-loss drug franchise hit a stumbling block Friday, wiping out nearly $100 billion of the drugmaker ...

(CNN) — Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more ...

Novo Nordisk A/S (NYSE:NVO) stock is down 18.9% to trade at $82.25 at last check, after the pharmaceutical company's weight loss drug CagriSema missed expectations of a late-stage study.